Research
Energy balance
Tirzepatide induces significant weight loss: 7.5 kg (5 mg/week), 11 kg (10 mg/week), and 12 kg (15 mg/week) compared to placebo.
TZP can be considered for weight management in patients with T2D and obesity.
StrongSupportsmedium confidence
Compared to placebo, TZP induces a significant weight loss: 7.5 (5 mg/week); 11 (10 mg/week); and 12 kg (15 mg/week).
Why this rating
Based on data from human studies.
Source
Is Tirzepatide the New Game Changer in Type 2 Diabetes?
Giuseppe Lisco et al. · Endocrines · 2024
DOI 10.3390/endocrines5010005
reviewCited 7×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →